Archive: December 2015

Emerging Therapies in Relapsed and Refractory Peripheral T-Cell Lymphoma

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Spencer H. Bachow, MD, and Owen A. O’Connor, MD, PhD The authors are affiliated […]

Advances in Immunotherapy for Non–Small Cell Lung Cancer

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Karen L. Reckamp, MD Dr Reckamp is an associate professor in the Department of […]

Programmed Death 1 Immune Checkpoint Inhibitors

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Meghna S. Trivedi, MD, Brianna Hoffner, BA, RN, MSN, Jennifer L. Winkelmann, BSN, RN, […]

The Right Questions to Ask in New Trials of Immunotherapy

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Based on a presentation by David McDermott, MD, at the Kidney Cancer Symposium Now […]

Use of PCR Testing in Chronic Myeloid Leukemia

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Elias J. Jabbour, MD Associate Professor Department of Leukemia The University of Texas MD […]

Emerging Gene Mutation Targets in Lung Cancer

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Bruce E. Johnson, MD Professor of Medicine Harvard Medical School Boston, Massachusetts H&O How […]

The Current and Future Applications of Immunopharmacogenomics

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Yusuke Nakamura, MD, PhD Professor of Medicine Departments of Medicine and Surgery The University […]

The Use of Genetic Alterations in the Development of Liver Cancer Drugs

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Ghassan K. Abou-Alfa, MD Associate Professor Gastrointestinal Oncology Service Memorial Sloan Kettering Cancer Center […]

Molecular Approaches to Tumor Inhibition in Melanoma

Michael A. Davies, MD, PhD

  H&O What molecular agents are currently available for use in melanoma? MD The US Food Administration (FDA) has approved several molecularly targeted agents for use […]

Hem/Onc News

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Devon Schuyler Osimertinib Approved for Use in NSCLC The US Food and Drug Administration […]

Letter From the Editor: A Thankful End of the Year

Clinical Advances in Hematology & Oncology December 2015, Volume 13, Issue 12 Bruce D. Cheson, MD It is time for my (almost) annual end-of-the-year epistle, when […]

Back to Archive